CoChat

Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation

Open access
Arnold, Suzanne V., Chinnakondepalli, Khaja M., Spertus, John A., Magnuson, Elizabeth A., Baron, Suzanne J., Kar, Saibal, Lim, D. Scott, Mishell, Jacob M., Abraham, William T., Lindenfeld, JoAnn A., Mack, Michael J., Stone, Gregg W., Cohen, David J. · 2019 · Journal of the American College of Cardiology
Cited by 130

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background In the COAPT trial, transcatheter mitral valve repair (TMVr) with the edge-to-edge device led to reduced heart failure (HF) hospitalizations and improved survival in patients with symptomatic HF and 3-4+ secondary mitral regurgitation (MR) on maximally-tolerated medical therapy. Given the advanced age and comorbidities of these patients, improvement in health status is also an important treatment goal. Objective To understand the health status outcomes of patients with HF and 3-4+ secondary MR treated with TMVr versus standard care. Methods The COAPT trial randomized patients with HF and 3-4+ secondary MR to TMVr (n=302) or standard care (n=312). Health status was assessed at baseline and at 1, 6, 12, and 24 months with the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the SF-36 health status survey. The primary health status endpoint was the KCCQ overall summary score (KCCQ-OS; range 0-100; higher=better; minimum clinically important difference=5 points). Results At baseline, patients had substantially impaired health status (mean KCCQ-OS 52.4 ± 23.0). While health status was unchanged over time in the standard care arm, patients randomized to TMVr demonstrated substantial improvement in the KCCQ-OS at 1 month (mean between-group difference 15.9 points, 95% CI 12.3 to 19.5) with only slight attenuation of this benefit through 24 months (mean between-group difference 12.8 points, 95% CI 7.5 to 18.2). At 24 months, 36.4% of TMVr patients were alive with a moderately large (≥10-point) improvement vs. 16.6% of standard care patients (p<0.001), for a number needed to treat of 5.1 patients (95% CI 3.6 to 8.7). TMVr patients also reported better generic health status at each timepoint (24-month mean difference in SF-36 summary scores: physical 3.6 points, 95% CI 1.4-5.8; mental 3.6 points, 95% CI 0.8-6.4). Conclusion Among patients with symptomatic HF and 3-4+ secondary MR receiving maximally-tolerated medical therapy, TMVr with the edge-to-edge device resulted in substantial early and sustained health status improvement compared with medical therapy alone.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.02.010

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 130

Metadata

Authors
Arnold, S. V., Chinnakondepalli, K. M., Spertus, J. A., Magnuson, E. A., Baron, S. J., Kar, S., Lim, D. S., Mishell, J. M., Abraham, W. T., Lindenfeld, J. A., Mack, M. J., Stone, G. W., & Cohen, D. J.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2019-05
Volume
73
Issue
17
Pages
2123-2132
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2921848961
Cited by
130
References
4
FWCI
12.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.